Not Yet Recruiting INTERVENTIONAL NCT07559474

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

A Phase 1, Open-Label Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Sponsor: Incyte Corporation

Conditions Hepatic Insufficiency Liver Diseases

Interventions INCB123667

Updated 1 time since 2026 Last updated: Apr 24, 2026 Started: May 15, 2026 Primary completion: Apr 13, 2027 Completion: Apr 13, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07559474, this observational or N/A phase trial focuses on Hepatic Insufficiency and Liver Diseases and remains actively recruiting participants. Sponsored by Incyte Corporation, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

1 version recorded

Not Yet Recruiting [daily]

Eligibility Summary

This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with moderate or severe hepatic impairment.

Contact Information

Sponsor contact:

Incyte Corporation

Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.